pMIG-hNFATc2 Citations (2)

Originally described in: Identification of Novel Nuclear Factor of Activated T Cells (NFAT)-Associated Proteins in T cells.
Gabriel CH, Gross F, Karl M, Stephanowitz H, Hennig AF, Weber M, Gryzik S, Bachmann I, Hecklau K, Wienands J, Schuchhardt J, Herzel H, Radbruch A, Krause E, Baumgrass R J Biol Chem. 2016 Sep 16. pii: jbc.M116.739326. PubMed Journal

---

Articles Citing pMIG-hNFATc2

Articles
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity. Bhingarkar A, Wang Y, Hoshitsuki K, Eichinger KM, Rathod S, Zhu Y, Lyu H, McNutt AT, Moreland LW, McDermott L, Koes DR, Fernandez CA. Front Pharmacol. 2025 Jan 9;15:1397995. doi: 10.3389/fphar.2024.1397995. eCollection 2024. PubMed
NFATc1 drives Orai3 transcription and proteolysis by harnessing epigenome differences in the MARCH8 promoter. Raju S, Sharma A, Dahiya S, Ranjan G, Motiani RK. EMBO J. 2025 Nov;44(21):6137-6167. doi: 10.1038/s44318-025-00572-4. Epub 2025 Sep 29. PubMed

If you have published an article using this material, please email us at to have your article added to this page.